Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01417988
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Berto J Bouma | Marjolein Spiering | Prof. dr. R.O. Schlingemann | Prof. Jan Prins | Prof JMA Lange | Ramon Gorter

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Appendicitis (Phase 4)

Congenital Abnormalities (Phase 2)

Edema (Phase 3)

Hodgkin Disease (Phase 1)

Lymphoma (Phase 1)

Macular Edema (Phase 3)

Neoplasms (Phase 4)

Recurrence (Phase 1)

Tuberculosis (Phase 4)

Vascular Malformations (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 13